Item 7.01. Regulation FD.

Attached hereto as Exhibit 99.1 is a presentation that PharmAthene, Inc. plans to give at the Rodman & Renshaw Annual Global Investment Conference on September 10, 2012.

In accordance with General Instruction B.2. of Form 8-K, the information in this Current Report on Form 8-K, including the attached Exhibit 99.1, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit No. Description

99.1 PharmAthene Presentation, dated September 10, 2012.